TGFB1 and acute respiratory distress syndrome: To evaluate the potential utility of the new RNAi agents for clinical application, we prepared nkRNA and PnkRNA directed against mouse or human TGF-β1 and used them to treat wild type or human TGF-β1 TG mice with LPS-induced ALI.